Striatal glutamatergic hyperactivity in Parkinson's disease

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · see citing works

Modulation of Striatal Projection Systems by Dopamine

Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,700 · see citing works

Pathological synchronization in Parkinson's disease: networks, models and treatments

Hammond, C., Bergman, H., & Brown, P. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.05.004 · Cited by 1,619 · see citing works

6-Hydroxy-dopamine induced degeneration of central monoamine neurons.

Ungerstedt, U. (1968) · European Journal of Pharmacology · doi:10.1016/0014-2999(68)90164-7 · Cited by 1,516 · see citing works

Concurrent activation of striatal direct and indirect pathways during action initiation

Cui, G., Jun, S. B., Jin, X., Pham, M. D., Vogel, S. S., Lovinger, D. M., & Costa, R. M. (2013) · Nature · doi:10.1038/nature11846 · Cited by 1,260 · see citing works

The basal ganglia: a vertebrate solution to the selection problem?

Redgrave, P., Prescott, T. J., & Gurney, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00319-4 · Cited by 1,199 · see citing works

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

Björklund, L. M., Sánchez‐Pernaute, R., Chung, S., Andersson, T., CHEN, I. Y., McNaught, K. S. P., Brownell, A., Jenkins, B. G., Wahlestedt, C., Kim, K. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022438099 · Cited by 1,170 · see citing works

The basal ganglia

Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051 · see citing works

Regulation of firing of dopaminergic neurons and control of goal-directed behaviors

Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034 · see citing works

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder

Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M.-L., Fontaine, D., Montcel, S. T. D., Yelnik, J., Chéreau, I., Arbus, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708514 · Cited by 965 · see citing works

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

Luk, K. C., Song, C., O’Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 958 · see citing works

Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein

Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, Á., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 901 · see citing works

Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes

Roy, N. S., Cléren, C., Singh, S. K., Yang, L., Beal, M. F., & Goldman, S. A. (2006) · Nature Medicine · doi:10.1038/nm1495 · Cited by 822 · see citing works

Direct and indirect pathways of basal ganglia: a critical reappraisal

Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Filippo, M. D. (2014) · Nature Neuroscience · doi:10.1038/nn.3743 · Cited by 820 · see citing works

Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP

Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803 · see citing works

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models

Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · see citing works

A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus

Plenz, D., & Kital, S. T. (1999) · Nature · doi:10.1038/23281 · Cited by 715 · see citing works

Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

Obeso, J. A., Rodríguez-Oroz, M. C., Benítez‐Temiño, B., Blesa, F. J., Guridi, J., Marı́n, C., & Rodrı́guez, M. (2008) · Movement Disorders · doi:10.1002/mds.22062 · Cited by 669 · see citing works

Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat

Kirik, D., Rosenblad, C., & Björklund, A. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6848 · Cited by 663 · see citing works

Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert

Reiner, A., & Levitz, J. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.018 · Cited by 637 · see citing works

Move to the rhythm: oscillations in the subthalamic nucleus–external globus pallidus network

Bevan, M. D. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02235-x · Cited by 633 · see citing works

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017

Deuschl, G., Beghi, E., Fazekas, F., Varga, T., Christoforidi, K., Sipido, E., Bassetti, C. L., Vos, T., & Feigin, V. L. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30190-0 · Cited by 633 · see citing works

Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP

Dauer, W. T., Kholodilov, N. G., Vila, M., Trillat, A., Goodchild, R. E., Larsen, K. E., Staal, R. G. W., Tieu, K., Schmitz, Y., Yuan, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172514599 · Cited by 580 · see citing works

Firing Patterns and Correlations of Spontaneous Discharge of Pallidal Neurons in the Normal and the Tremulous 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Vervet Model of Parkinsonism

Raz, A., Vaadia, E., & Bergman, H. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08559.2000 · Cited by 567 · see citing works

Pathophysiology of Parkinsonism

Galván, A., & Wichmann, T. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.03.017 · Cited by 551 · see citing works

The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics

Rodríguez‐Oroz, M. (2001) · Brain · doi:10.1093/brain/124.9.1777 · Cited by 468 · see citing works

Animal models of Parkinson’s disease

Blandini, F., & Armentero, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08491.x · Cited by 428 · see citing works

Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels

Calabresi, P., Pisani, A., Mercuri, N. B., & Bernardi, G. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00119.x · Cited by 418 · see citing works

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

Calabresi, P., Filippo, M. D., Ghiglieri, V., Tambasco, N., & Picconi, B. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70218-0 · Cited by 390 · see citing works

α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

Vila, M., Vukosavić, S., Jackson-Lewis, V. R., Neystat, M., Jakowec, M. W., & Przedborski, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740721.x · Cited by 388 · see citing works

Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity

Calabresi, P., Gubellini, P., Centonze, D., Picconi, B., Bernardi, G., Chergui, K., Svenningsson, P., Fienberg, A. A., & Greengard, P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08443.2000 · Cited by 379 · see citing works

Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells

Iovino, L., Tremblay, M., & Civiero, L. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.011 · Cited by 370 · see citing works

Pathological roles of α-synuclein in neurological disorders

Vekrellis, K., Xilouri, M., Emmanouilidou, E., Rideout, H. J., & Stefanis, L. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70213-7 · Cited by 359 · see citing works

Diametric neural ensemble dynamics in parkinsonian and dyskinetic states

Parker, J. G., Marshall, J. D., Ahanonu, B., Wu, Y., Kim, T. H., Grewe, B. F., Zhang, Y., Li, J. Z., Ding, J., Ehlers, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0090-6 · Cited by 342 · see citing works

Electrophysiology of dopamine-denervated striatal neurons

Brink, E. E., & Mackel, R. G. (1993) · Brain · doi:10.1093/brain/116.2.433 · Cited by 321 · see citing works

The 6-hydroxydopamine model: News from the past

Blandini, F., Armentero, M., & Martignoni, E. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.015 · Cited by 311 · see citing works

Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations

Borgohain, R., Szász, J. A., Stanzione, P., Meshram, C., Bhatt, M. H., Chirilineau, D., Stocchi, F., Lucini, V., Giuliani, R., Forrest, E. A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25751 · Cited by 293 · see citing works

Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia

Fieblinger, T., Graves, S. M., Sebel, L. E., Alcacer, C., Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Cenci, M. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6316 · Cited by 293 · see citing works

MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons

Kowall, N. W., Hantraye, P., Brouillet, E., Beal, M. F., McKee, A. C., & Ferrante, R. J. (2000) · Neuroreport · doi:10.1097/00001756-200001170-00041 · Cited by 291 · see citing works

Plasticity of Synapses in the Rat Neostriatum after Unilateral Lesion of the Nigrostriatal Dopaminergic Pathway

Ingham, C. A., Hood, S. H., Taggart, P., & Arbuthnott, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04732.1998 · Cited by 291 · see citing works

Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors

Calabresi, P., Saiardi, A., Pisani, A., Baik, J., Centonze, D., Mercuri, N. B., Bernardi, G., & Borrelli, E. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04536.1997 · Cited by 287 · see citing works

A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia

Gardoni, F., Picconi, B., Ghiglieri, V., Polli, F., Bagetta, V., Bernardi, G., Cattabeni, F., Luca, M. D., & Calabresi, P. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5326-05.2006 · Cited by 268 · see citing works

Initiation and propagation of α-synuclein aggregation in the nervous system

Hijaz, B. A., & Volpicelli‐Daley, L. A. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00368-6 · Cited by 267 · see citing works

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease

Ilijić, E., Guzmán, J. N., & Surmeier, D. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.007 · Cited by 260 · see citing works

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Chase, T. N., & Oh, J. D. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00018-5 · Cited by 250 · see citing works

The thalamostriatal system in normal and diseased states

Smith, Y., Galván, A., Ellender, T. J., Doig, N. M., Villalba, R. M., Huerta-Ocampo, I., Wichmann, T., & Bolam, J. P. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00005 · Cited by 244 · see citing works

Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment

Marino, M. J., Williams, D. L., O’Brien, J. A., Valenti, O., McDonald, T. P., Clements, M. K., Wang, R., DiLella, A. G., Hess, J. F., Kinney, G. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835724100 · Cited by 240 · see citing works

Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease

Borgohain, R., Szász, J. A., Stanzione, P., et al. (2014) · Movement Disorders · doi:10.1002/mds.25961 · Cited by 234 · see citing works

Cortical Slow Oscillatory Activity Is Reflected in the Membrane Potential and Spike Trains of Striatal Neurons in Rats with Chronic Nigrostriatal Lesions

Tseng, K. Y., Kasanetz, F., Kargieman, L., Riquelme, L. A., & Murer, M. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06430.2001 · Cited by 233 · see citing works

The ‘magic’ of -dopa: why is it the gold standard Parkinson's disease therapy?

Mercuri, N. B., & Bernardi, G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.002 · Cited by 232 · see citing works

Post‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia

Cenci, M. A., & Lundblad, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04124.x · Cited by 220 · see citing works

Contributions of non-human primates to neuroscience research

Capitanio, J. P., & Emborg, M. E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60489-4 · Cited by 214 · see citing works

Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion

Meshul, C. K., Emre, N., Nakamura, C. M., Allen, C., Donohue, M., & Buckman, J. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00189-4 · Cited by 209 · see citing works

A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease

Ambrosi, G., Cerri, S., & Blandini, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1149-z · Cited by 195 · see citing works

Nonhuman Primate Models of Parkinson's Disease

Emborg, M. E. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.339 · Cited by 190 · see citing works

Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat

Pan, H. S., & Walters, J. R. (1988) · Synapse · doi:10.1002/syn.890020612 · Cited by 190 · see citing works

Modeling Parkinson's Disease in Primates: The MPTP ModelPreprint

Porras, G., Li, Q., & Bézard, E. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009308 · Cited by 180 · see citing works

L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice

Suárez, L. M., Solís, Ó., Caramés, J. M., Taravini, I. R. E., Solís, J. M., Murer, M. G., & Moratalla, R. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.006 · Cited by 178 · see citing works

Dopamine-dependent synaptic plasticity in striatum during in vivo development

Tang, K., Low, M. J., Grandy, D. K., & Lovinger, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1255 · Cited by 171 · see citing works

Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease

Sgambato, V., & Cenci, M. A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.005 · Cited by 169 · see citing works

Distinct Levels of Dopamine Denervation Differentially Alter Striatal Synaptic Plasticity and NMDA Receptor Subunit Composition

Paillé, V., Picconi, B., Bagetta, V., Ghiglieri, V., Sgobio, C., Filippo, M. D., Viscomi, M. T., Giampà, C., Fusco, F. R., Gardoni, F., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2149-10.2010 · Cited by 168 · see citing works

Frequency-specific and D 2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling

Yin, H. H., & Lovinger, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510797103 · Cited by 166 · see citing works

Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons

Lindefors, N., & Ungerstedt, U. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90463-j · Cited by 158 · see citing works

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration

Ghiglieri, V., Calabrese, V., & Calabresi, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00295 · Cited by 158 · see citing works

The Metabotropic Receptor mGluR6 May Signal Through Go, But Not Phosphodiesterase, in Retinal Bipolar Cells

Nawy, S. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-08-02938.1999 · Cited by 157 · see citing works

Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia

Ryan, M., Bair-Marshall, C. J., & Nelson, A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.059 · Cited by 155 · see citing works

Dopaminergic modulation of striatal networks in health and Parkinson's disease

Surmeier, D. J., Graves, S. M., & Shen, W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.008 · Cited by 154 · see citing works

Chronic l ‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

Robelet, S., Melon, C., Guillet, B. A., Salin, P., & Goff, L. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03591.x · Cited by 150 · see citing works

The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D 2 /A 2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease

Tozzi, A., de Iure, A., Filippo, M. D., Tantucci, M., Costa, C., Borsini, F., Ghiglieri, V., Giampà, C., Fusco, F. R., Picconi, B., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4082-10.2011 · Cited by 148 · see citing works

Synaptically driven state transitions in distal dendrites of striatal spiny neurons

Plotkin, J. L., Day, M., & Surmeier, D. J. (2011) · Nature Neuroscience · doi:10.1038/nn.2848 · Cited by 147 · see citing works

The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease

Lin, K.-J., Lin, K.-L., Chen, S., Liou, C., Chuang, Y., Lin, H., & Lin, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215312 · Cited by 141 · see citing works

Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice

Parker, P. R. L., Lalive, A. L., & Kreitzer, A. C. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.038 · Cited by 132 · see citing works

Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit

Tozzi, A., Sciaccaluga, M., Loffredo, V., Megaro, A., Ledonne, A., Cardinale, A., Federici, M., Bellingacci, L., Paciotti, S., Ferrari, E. S., et al. (2021) · Brain · doi:10.1093/brain/awab242 · Cited by 127 · see citing works

Pathophysiologic basis of surgery for Parkinson's disease.

Obeso, J. A., Rodríguez-Oroz, M. C., Rodriguez, M., Macıás, R., Álvarez, L., Guridi, J., Vitek, J. L., & DeLong, M. R. (2000) · PubMed · Cited by 126 · see citing works

L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia

Suárez, L. M., Solís, Ó., Aguado, C., Luján, R., & Moratalla, R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw263 · Cited by 122 · see citing works

Aberrant Restoration of Spines and their Synapses in L-DOPA-Induced Dyskinesia: Involvement of Corticostriatal but Not Thalamostriatal Synapses

Zhang, Y., Meredith, G. E., Mendoza‐Elias, N., Rademacher, D. J., Tseng, K. Y., & Steece‐Collier, K. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0288-13.2013 · Cited by 121 · see citing works

Input- and Cell-Type-Specific Endocannabinoid-Dependent LTD in the Striatum

Wu, Y., Kim, J., Tawfik, V. L., Lalchandani, R. R., Scherrer, G., & Ding, J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.12.005 · Cited by 117 · see citing works

Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism

Beurrier, C., Lopez, S., Révy, D., Selvam, C., Goudet, C., Lhérondel, M., Gubellini, P., Goff, L. K., Acher, F., Pin, J., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-131789 · Cited by 117 · see citing works

Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration

Durante, V., de Iure, A., Loffredo, V., Vaikath, N. N., Risi, M. D., Paciotti, S., Quiroga‐Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., et al. (2019) · Brain · doi:10.1093/brain/awz065 · Cited by 117 · see citing works

Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias

Rascol, O., Fox, S. H., Gasparini, F., Kenney, C., Paolo, T. D., & Gomez‐Mancilla, B. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.05.003 · Cited by 115 · see citing works

Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N -Methyl-D-Aspartate Receptor Subunit

Tozzi, A., de Iure, A., Bagetta, V., Tantucci, M., Durante, V., Quiroga‐Varela, A., Costa, C., Filippo, M. D., Ghiglieri, V., Latagliata, E. C., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.013 · Cited by 112 · see citing works

Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson’s Disease Models

Tanimura, A., Du, Y., Kondapalli, J., Wokosin, D. L., & Surmeier, D. J. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.004 · Cited by 111 · see citing works

Inversion of Dopamine Responses in Striatal Medium Spiny Neurons and Involuntary Movements

Li, L., DeLong, M. R., & Papa, S. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1176-08.2008 · Cited by 108 · see citing works

Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys

Cao, X., Li, L., Hadcock, J. R., Iredale, P. A., Griffith, D. A., Menniti, F. S., Factor, S. A., Greenamyre, J. T., & Papa, S. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125666 · Cited by 101 · see citing works

Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats

Jiang, H., Jackson-Lewis, V. R., Muthane, U. B., Dollison, A. M., Ferreira, M., Espinosa, A., Parsons, B., & Przedborski, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90925-d · Cited by 99 · see citing works

Striatal cholinergic neurotransmission requires VGLUT3

Nelson, A. B., Bussert, T. G., Kreitzer, A. C., & Seal, R. P. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0901-14.2014 · Cited by 99 · see citing works

Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease

Shimoji, M., Zhang, L., Mandir, A. S., Dawson, V. L., & Dawson, T. M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.01.012 · Cited by 97 · see citing works

Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury

VanLeeuwen, J., Petzinger, G. M., Walsh, J. P., Akopian, G. K., Vuckovic, M., & Jakowec, M. W. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22216 · Cited by 94 · see citing works

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment

Calon, F., Morissette, M., Ghribi, O., Goulet, M., Grondin, R., Blanchet, P. J., Bédard, P. J., & Paolo, T. D. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00237-8 · Cited by 93 · see citing works

NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients

Mellone, M., Stanic, J., Hernández, L. F., Iglesias, E., Zianni, E., Longhi, A., Prigent, A., Picconi, B., Calabresi, P., Hirsch, É. C., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00245 · Cited by 84 · see citing works

Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism

Picconi, B., Centonze, D., Rossi, S., et al. (2004) · Brain · doi:10.1093/brain/awh190 · Cited by 82 · see citing works

Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia

Perez‐Lloret, S., & Rascol, O. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1869-1 · Cited by 81 · see citing works

Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research

Litim, N., Morissette, M., & Paolo, T. D. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.036 · Cited by 80 · see citing works

Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson’s disease

Singh, A. P., Mewes, K., Gross, R. E., DeLong, M. R., Obeso, J. A., & Papa, S. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606792113 · Cited by 78 · see citing works

Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease

Bagetta, V., Sgobio, C., Pendolino, V., Del Papa, G., Tozzi, A., Ghiglieri, V., Giampà, C., Zianni, E., Gardoni, F., Calabresi, P., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2664-12.2012 · Cited by 74 · see citing works

Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat

MacLeod, N. K., Ryman, A., & Arbuthnott, G. W. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90041-2 · Cited by 73 · see citing works

Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias

Gardoni, F., Sgobio, C., Pendolino, V., Calabresi, P., Luca, M. D., & Picconi, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.019 · Cited by 73 · see citing works

Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment

Cuomo, D., Martella, G., Barabino, E., Platania, P., Vita, D., Madeo, G., Selvam, C., Goudet, C., Oueslati, N., Pin, J., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06036.x · Cited by 73 · see citing works

In Vivo Extracellular Recording of Striatal Neurons in the Awake Rat Following Unilateral 6-Hydroxydopamine Lesions

Chen, M.-T., Morales, M., Woodward, D. J., et al. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7730 · Cited by 72 · see citing works

Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats

Kita, H., & Kita, T. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00042 · Cited by 72 · see citing works

Modeling Parkinson's disease in monkeys for translational studies, a critical analysis

Potts, L. F., Wu, H., Singh, A. P., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.014 · Cited by 71 · see citing works

Group III and subtype 4 metabotropic glutamate receptor agonists: Discovery and pathophysiological applications in Parkinson's disease

Amalric, M., Lopez, S., Goudet, C., Fisone, G., Battaglia, G., Nicoletti, F., Pin, J., & Acher, F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.026 · Cited by 70 · see citing works

mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia

Sebastianutto, I., & Cenci, M. A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.03.003 · Cited by 69 · see citing works

Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation

Mazzitelli, M., Palazzo, E., Maione, S., & Neugebauer, V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00383 · Cited by 63 · see citing works

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

Elmer, L. W., Juncos, J. L., Singer, C., et al. (2018) · CNS Drugs · doi:10.1007/s40263-018-0498-4 · Cited by 62 · see citing works

Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease

Divito, C. B., Steece‐Collier, K., Case, D. T., Williams, S. G., Stancati, J. A., Zhi, L., Rubio, M. E., Sortwell, C. E., Collier, T. J., Sulzer, D. L., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2124-15.2015 · Cited by 61 · see citing works

Clinical Pharmacokinetics and Pharmacodynamics of Safinamide

Müller, T. H., & Foley, P. B. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0449-5 · Cited by 60 · see citing works

An m G lu4‐ P ositive A llosteric M odulator A lleviates P arkinsonism in P rimates

Charvin, D., Paolo, T. D., Bézard, E., et al. (2018) · Movement Disorders · doi:10.1002/mds.27462 · Cited by 60 · see citing works

Nicotinic Acetylcholine Receptor Signaling in Neuroprotection

Akaike, A., Shimohama, S., & Misu, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1 · Cited by 60 · see citing works

Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat

Nash, J. E., & Brotchie, J. M. (2002) · Movement Disorders · doi:10.1002/mds.10107 · Cited by 59 · see citing works

On the neuronal circuitry mediating l-DOPA-induced dyskinesia

Cenci, M. A., Jörntell, H., & Petersson, P. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1886-0 · Cited by 59 · see citing works

Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease

Amalric, M. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.001 · Cited by 58 · see citing works

Nondopaminergic Treatments for Parkinson’s Disease: Current and Future Prospects

Freitas, M. E., & Fox, S. H. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2016-0005 · Cited by 53 · see citing works

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia

Morari, M., Brugnoli, A., Pisanò, C. A., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245100 · Cited by 52 · see citing works

Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET

Logan, J., Volkow, N. D., Fowler, J. S., Wang, G., Fischman, M. W., Foltin, R. W., Abumrad, N. N., Vitkun, S. A., Gatley, S. J., Pappas, N. R., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4 · Cited by 50 · see citing works

Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates

Singh, A. P., Liang, L., Kaneoke, Y., Cao, X., & Papa, S. M. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00910.2014 · Cited by 50 · see citing works

Dopamine Oppositely Modulates State Transitions in Striosome and Matrix Direct Pathway Striatal Spiny Neurons

Prager, E. M., Dormán, D. B., Hobel, Z. B., Malgady, J. M., Blackwell, K. T., & Plotkin, J. L. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.028 · Cited by 48 · see citing works

Cortical Control of Subthalamic Neuronal Activity through the Hyperdirect and Indirect Pathways in Monkeys

Polyakova, Z., Chiken, S., Hatanaka, N., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0772-20.2020 · Cited by 47 · see citing works

Therapeutic potential of targeting glutamate receptors in Parkinson’s disease

Finlay, C. J., & Duty, S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1176-4 · Cited by 41 · see citing works

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients

Cattaneo, C., Jost, W. H., & Bonizzoni, E. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191765 · Cited by 40 · see citing works

Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine

Shen, W., Ren, W., Zhai, S., Yang, B., Vanoye, C. G., Mitra, A., George, A. L., & Surmeier, D. J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133398 · Cited by 39 · see citing works

Dopamine D1 Receptors Regulate Spines in Striatal Direct‐Pathway and Indirect‐Pathway Neurons

Suárez, L. M., Solís, Ó., Sanz‐Magro, A., Alberquilla, S., & Moratalla, R. (2020) · Movement Disorders · doi:10.1002/mds.28174 · Cited by 38 · see citing works

NMDA Receptor Gating of Information Flow through the Striatum In Vivo

Pomata, P. E., Belluscio, M., Riquelme, L. A., & Murer, M. G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4343-08.2008 · Cited by 37 · see citing works

Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism

Warre, R., Thiele, S. L., Talwar, S., Kamal, M., Johnston, T. H., Wang, S., Lam, D., Lo, C., Khademullah, C. S., Perera, G., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.013 · Cited by 37 · see citing works

Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease

Fox, S. H., Metman, L. V., Nutt, J. G., et al. (2017) · Movement Disorders · doi:10.1002/mds.26976 · Cited by 35 · see citing works

NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology

Mellone, M., Zianni, E., Stanic, J., Campanelli, F., Marino, G., Ghiglieri, V., Longhi, A., Thiolat, M.-L., Li, Q., Calabresi, P., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.021 · Cited by 35 · see citing works

The Anticonvulsant FCE 26743 is a Selective and Short-acting MAO-B Inhibitor Devoid of Inducing Properties towards Cytochrome P450-dependent Testosterone Hydroxylation in Mice and Rats

Benedetti, M. S., Marrari, P., Colombo, M., et al. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03736.x · Cited by 33 · see citing works

Memantine and reduced time with dyskinesia in Parkinson′s Disease

Wictorin, K., & Widner, H. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12468 · Cited by 32 · see citing works

Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia

Gangarossa, G., Guzmán, M. S., Prado, V. F., Prado, M. A. M., Daumas, S., Mestikawy, S. E., & Valjent, E. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.010 · Cited by 32 · see citing works

Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia

Gardoni, F., Morari, M., Kulisevsky, J., Brugnoli, A., Novello, S., Pisanò, C. A., Caccia, C., Mellone, M., Melloni, E., Padoani, G., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.251645 · Cited by 32 · see citing works

Transcranial Magnetic Stimulation Exerts “Rejuvenation” Effects on Corticostriatal Synapses after Partial Dopamine Depletion

Natale, G., Pignataro, A., Marino, G., Campanelli, F., Calabrese, V., Cardinale, A., Pelucchi, S., Marcello, E. E., Gardoni, F., Viscomi, M. T., et al. (2021) · Movement Disorders · doi:10.1002/mds.28671 · Cited by 30 · see citing works

Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Wang, W., Zhang, X., Zhang, Z., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00262 · Cited by 25 · see citing works

Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID)

Yang, K., Zhao, X., Wang, C., Zeng, C., Luo, Y., & Sun, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.614412 · Cited by 25 · see citing works

A case study of foliglurax, the first clinical mGluR4 PAM for symptomatic treatment of Parkinson’s disease: translational gaps or a failing industry innovation model?

Doller, D., Bespalov, A., Miller, R., Pietraszek, M., & Kalinichev, M. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1839047 · Cited by 21 · see citing works

Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias

Cerri, S., Siani, F., & Blandini, F. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1333598 · Cited by 18 · see citing works

Effects of safinamide on the glutamatergic striatal network in experimental Parkinson’s disease

Sciaccaluga, M., Mazzocchetti, P., Bastioli, G., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108024 · Cited by 18 · see citing works

Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates

Singh, A. P., Jenkins, M. A., Burke, K. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.095 · Cited by 17 · see citing works

The role of nonhuman primate models in the development of cell-based therapies for Parkinson’s disease

Vermilyea, S., & Emborg, M. E. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1708-9 · Cited by 14 · see citing works

Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease

Marino, G., Calabresi, P., & Ghiglieri, V. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00008-4 · Cited by 14 · see citing works

Modulation of Excitatory Transmission onto Midbrain Dopaminergic Neurons of the Rat by Activation of Group III Metabotropic Glutamate Receptors

Valenti, O., Marino, M. J., & Conn, P. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.058 · Cited by 11 · see citing works

Parkinson’s Disease: A Thalamostriatal Rebalancing Act?

Tritsch, N. X., & Carter, A. G. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.008 · Cited by 8 · see citing works

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights substrates of disability

Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Anatomy and Function of the Direct and Indirect Striatal Pathways

Soghomonian, J. (2016) · Innovations in cognitive neuroscience · doi:10.1007/978-3-319-42743-0_3 · Cited by 2 · see citing works

Quantal properties of S-type glutamatergic synaptic input to the striatal medium spiny neuron from neonate rat

Mori, A., Takahashi, T., Miyashita, Y., & Kasai, H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90391-3 · Cited by 3 · see citing works

Physiology of Basal Ganglia Disorders: An Overview

Hallett, M. (1993) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100047909 · Cited by 215 · see citing works

Ethanol Experience Enhances Glutamatergic Ventral Hippocampal Inputs To D1 Receptor-Expressing Medium Spiny Neurons In The Nucleus Accumbens Shell

Kircher, D. M., Aziz, H. C., Mangieri, R. A., & Morrisett, R. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.3051-18.2019 · Cited by 21 · see citing works

EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans

Lee, R., Sawin, E. R., Chalfie, M., Horvitz, H. R., & Avery, L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00159.1999 · Cited by 351 · see citing works